Sei Investments Co. Raises Position in Avantor, Inc. $AVTR

Sei Investments Co. boosted its stake in Avantor, Inc. (NYSE:AVTR) by 0.9% during the first quarter, HoldingsChannel reports. The institutional investor owned 5,287,850 shares of the company’s stock after buying an additional 46,707 shares during the quarter. Sei Investments Co.’s holdings in Avantor were worth $41,457,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Wellington Management Group LLP acquired a new position in shares of Avantor during the fourth quarter valued at approximately $268,584,000. Morgan Stanley lifted its position in shares of Avantor by 179.4% in the fourth quarter. Morgan Stanley now owns 17,468,418 shares of the company’s stock valued at $200,188,000 after acquiring an additional 11,216,565 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Avantor by 7.0% in the fourth quarter. Invesco Ltd. now owns 17,178,716 shares of the company’s stock worth $196,868,000 after acquiring an additional 1,125,348 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Avantor by 15.7% in the first quarter. Dimensional Fund Advisors LP now owns 16,894,649 shares of the company’s stock worth $132,443,000 after acquiring an additional 2,288,053 shares during the last quarter. Finally, Clarkston Capital Partners LLC raised its stake in Avantor by 0.6% in the 4th quarter. Clarkston Capital Partners LLC now owns 15,105,065 shares of the company’s stock valued at $173,104,000 after purchasing an additional 84,740 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Avantor

In other news, Director Gregory T. Lucier bought 10,000 shares of Avantor stock in a transaction on Friday, May 8th. The shares were bought at an average cost of $8.32 per share, with a total value of $83,200.00. Following the completion of the purchase, the director directly owned 60,000 shares of the company’s stock, valued at approximately $499,200. This trade represents a 20.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Simon Dingemans bought 25,000 shares of the firm’s stock in a transaction on Friday, May 1st. The stock was purchased at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the acquisition, the director directly owned 25,000 shares in the company, valued at $203,500. The trade was a ? increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.28% of the company’s stock.

Analyst Upgrades and Downgrades

AVTR has been the topic of several recent research reports. Wall Street Zen raised shares of Avantor from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. TD Cowen reissued a “hold” rating on shares of Avantor in a research note on Wednesday, July 15th. Wolfe Research lowered shares of Avantor to an “underperform” rating and set a $7.00 price target on the stock. in a research report on Monday, June 1st. Citigroup boosted their price target on shares of Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Finally, UBS Group set a $8.00 price objective on shares of Avantor in a research note on Wednesday, June 24th. Two equities research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $10.62.

Avantor Stock Performance

NYSE AVTR opened at $11.47 on Monday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.17 and a current ratio of 1.76. The stock’s fifty day moving average is $9.71 and its two-hundred day moving average is $9.40. The firm has a market capitalization of $7.83 billion, a P/E ratio of -14.16, a price-to-earnings-growth ratio of 6.37 and a beta of 0.94. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $15.93.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same period last year, the company earned $0.23 EPS. The company’s revenue for the quarter was up .0% on a year-over-year basis. On average, research analysts anticipate that Avantor, Inc. will post 0.79 earnings per share for the current year.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.